Immunic IMUX
NASDAQ IMUX
$12.78 +0.02 (+0.20%)
As of: Sep 4, 2026 · 2:23 PM EDT

Immunic (IMUX) EPS (Diluted) (2019 - 2026)

Analysis

Immunic (IMUX) EPS (Diluted) (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn 12.23
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 7.15
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.07 Bn 44.07 Bn - -3.06
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 2.05
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn 1.19
8 Royalty Pharma 28.42 Bn 27.58 Bn - 0.15
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn -0.06
10 Immunic 542.48 Mn 542.48 Mn - -0.80
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.80
Mar 31, 2026 -1.08
Dec 31, 2025 -1.49
Sep 30, 2025 -1.32
Jun 30, 2025 -2.03
Mar 31, 2025 -2.63
Dec 31, 2024 -2.52
Sep 30, 2024 -2.46
Jun 30, 2024 -2.15
Mar 31, 2024 -2.33
Dec 31, 2023 -5.15
Sep 30, 2023 -5.12
Jun 30, 2023 -5.41
Mar 31, 2023 -6.06
Dec 31, 2022 -17.80
Sep 30, 2022 -6.51
Jun 30, 2022 -6.78
Mar 31, 2022 -7.62
Dec 31, 2021 -9.18
Sep 30, 2021 -7.26